Novo Nordisk vs UBS Group AG
Vergleich der Marktkapitalisierung im Zeitverlauf
Novo Nordisk
$125.9B
Rang #131
UBS Group AG
$131.4B
Rang #126
Marktkapitalisierung im Zeitverlauf
Wichtige Momente
- Novo Nordisk überholte UBS Group AG bis 2010
- UBS Group AG überholte Novo Nordisk bis 2011
- Novo Nordisk überholte UBS Group AG bis 2012
- UBS Group AG überholte Novo Nordisk bis 2013
- Novo Nordisk überholte UBS Group AG bis 2014
- UBS Group AG überholte Novo Nordisk bis 2026
Vergleich Jahr für Jahr
| Jahr | Novo Nordisk | UBS Group AG | Spitzenreiter |
|---|---|---|---|
| 2026 | $125.9B | $131.4B | UBS Group AG |
| 2025 | $152.9B | $131.3B | Novo Nordisk |
| 2024 | $285.3B | $94.7B | Novo Nordisk |
| 2023 | $315.6B | $86.7B | Novo Nordisk |
| 2022 | $209.4B | $55.5B | Novo Nordisk |
| 2021 | $161.6B | $51.4B | Novo Nordisk |
| 2020 | $92.0B | $38.1B | Novo Nordisk |
| 2019 | $81.6B | $35.0B | Novo Nordisk |
| 2018 | $61.4B | $33.2B | Novo Nordisk |
| 2017 | $67.2B | $46.8B | Novo Nordisk |
| 2016 | $49.6B | $41.6B | Novo Nordisk |
| 2015 | $75.8B | $48.1B | Novo Nordisk |
| 2014 | $48.6B | $40.5B | Novo Nordisk |
| 2013 | $36.5B | $39.6B | UBS Group AG |
| 2012 | $33.0B | $32.4B | Novo Nordisk |
| 2011 | $23.3B | $25.2B | UBS Group AG |
| 2010 | $43.8B | $34.5B | Novo Nordisk |
| 2009 | $22.7B | $36.7B | UBS Group AG |
| 2008 | $9.1B | $33.4B | UBS Group AG |
| 2007 | $22.1B | $117.9B | UBS Group AG |
| 2006 | $7.7B | $161.9B | UBS Group AG |
| 2005 | $5.7B | $136.7B | UBS Group AG |
| 2004 | $9.4B | $104.2B | UBS Group AG |
| 2003 | $7.5B | $92.6B | UBS Group AG |
| 2002 | $6.2B | $73.5B | UBS Group AG |
| 2001 | $10.3B | $91.6B | UBS Group AG |